Clover Corporation Limited (ASX: CLV) - ETF Exposure

Current share price for CLV : $1.000 0.005 (0.50%)⁺

Clover Corporation Limited (CLV) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It develop and produce encapsulated bioactive ingredients, specialising in nutritional oils for infant formula, medical foods, and functional foods. The Company deliver nutritional solutions that enhance product stability, bioavailability, and health benefits.

CLV General Information ⁺

ASX Code	CLV
Website	http://www.clovercorp.com.au
Industry/Sector	Specialty Chemicals
Market Cap ($M)	166
CLV Share Price	$1.000
Day High	$1.000
Day Low	$0.980
Last Close	$0.995
CLV Share Price Movement	$0.01 ( 0.50% )

Prices as at 16:40, 30 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to CLV

Clover Corporation Limited (CLV) is held across 3 ETFs spanning strategies that include specialty chemicals exposure . Its weighting in those funds means performance can have an outsized influence - when CLV moves, funds like DACE and DAVA that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to CLV , while the average exposure across all 3 ETFs that hold it is around 0% .

Top ETF holdings

Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%
Dimensional Australian Value Trust - Active ETF (DAVA) ~ 0%

Last updated: ETF data and holdings as at 23 October 2026

Own CLV directly or through an ETF?

How does holding Clover Corporation Limited (CLV) shares directly compare to ETFs that include it?

	CLV Direct	DACE ASX	DAVA ASX
Holdings	1 company	501 holdings	183 holdings
CLV Weight	100%	0%	0%
Diversification	Single Stock	Broad	Broad
Annual Cost	Brokerage only	0.28% p.a.	0.34% p.a.
Approx. Yield	2.3%	3.17%	6.53%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not CLV's direct yield. Annual cost uses each ETF's MER.

CLV Exposure on $10,000 investment

How a $10,000 investment in Clover Corporation Limited (CLV) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Clover Corporation Limited (CLV)	Direct share	$1.000	-1.48%	-$148	$9,852
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$18.600	1.47%	+$147	$10,147
Dimensional Australian Value Trust - Active ETF (DAVA)	Equity - Australia Strategy	$31.870	1.37%	+$137	$10,137

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Clover Corporation Limited (CLV) ETFs

3 ETFs hold Clover Corporation Limited (CLV).

ETF	CLV Weight	MER	Yield
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3.17%
Dimensional Australian Value Trust - Active ETF (DAVA)	0%	0.34%	6.53%

View all 3 ETFs

Clover Corporation Limited (CLV) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	1.25¢	100%	20 Oct 2026	19 Nov 2026	-	-	-
Result	1¢	100%	15 Apr 2026	30 Apr 2026	-	-	-
HFResult	1¢	100%	20 Oct 2025	20 Nov 2025	-	-	-

See all dividends from Clover Corporation Limited (CLV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Clover Corporation Limited (CLV) price-sensitive announcements

CLV - Clover 2026 Results Presentation

Clover Corporation Limited’s FY26 Results Presentation reports a strong full-year performa

Clover Corporation Limited (CLV)
23 Sep 2026 | 8:55 AM

CLV - Clover 2026 Full Year Market Announcement

Clover Corporation Limited (ASX: CLV) announced record FY26 results for the year ended 31

Clover Corporation Limited (CLV)
23 Sep 2026 | 8:29 AM

CLV - Clover 2026 Appendix 4E

Clover Corporation Limited’s ASX Appendix 4E Preliminary Final Report for the Australian f

Clover Corporation Limited (CLV)
23 Sep 2026 | 8:28 AM

CLV - Clover Board Succession

Clover Corporation Limited announced board succession plans under which Chairman Rupert Ha

Clover Corporation Limited (CLV)
23 Sep 2026 | 8:17 AM

Clover Corporation Limited (CLV) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Change of Director's Interest	29 Oct 2026 11:09AM	$0.990	$1.000	risen by 1.01%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Change of Director's Interest	28 Oct 2026 8:34AM	$1.005	$1.000	fallen by 0.50%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Change of Director's Interest Notice	20 Oct 2026 8:37AM	$1.030	$1.000	fallen by 2.91%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Notice of 2026 AGM, Proxy Forms and Annual Accounts	16 Oct 2026 10:05AM	$1.030	$1.000	fallen by 2.91%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Update - Notification of buy-back - CLV	15 Oct 2026 12:54PM	$1.020	$1.000	fallen by 1.96%
Clover Corporation Limited (CLV) ORDINARY FULLY PAID	Materials	$167	Substantial Shareholder Notice	13 Oct 2026 3:58PM	$1.015	$1.000	fallen by 1.48%

CLV Financial Summary

Year to Jul	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026A	$10.46	$6.30	49.10%	12.40	2.30	2.90%	100.0%
2025A	$7.02	$4.20	361.50%	11.10	1.80	3.80%	100.0%
2024A	$1.52	$0.90	-75.50%	83.80	0.80	1.00%	100.0%

CLV Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Clover Corporation Limited (CLV)	$166M	0.4905	0.0000	0.0000	15.8946	0.0000	0.0000	2.26%	0.00%	0.00%

CLV Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.20	16.00	2.14	0.00
Market	0.30	13.20	1.03	0.74
Sector	1.55	11.90	1.34	0.43

CLV Directors

Name	Position	Start Date
Mr Peter J Davey	Chief Executive Officer, Managing Director	16 Dec 2014
Mr Ian David Glasson	Non-Executive Director	1 Feb 2017
Ms Toni Brendish	Non-Executive Director	20 Oct 2020
Mr Brett Hewlett	Non-Executive Director	1 Oct 2026
Dr Simon Green	Non-Executive Director	20 Oct 2020
Ms Fiona Pearse	Non-Executive Director	1 Aug 2025
Mr Rupert Anthony Harrington	Non-Executive Director, Non-Executive Chairman	1 Jul 2015

Clover Corporation Limited (CLV) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
27 Oct 2026	HEWLETT, Brett	Buy	Indirect Shares	10,000	$1.001	$10,005.000
20 Oct 2026	GLASSON, Ian	Buy	Indirect Shares	50,000	$1.030	$51,500.000
9 Oct 2026	ALLIBON, Andrew	Buy	Indirect Shares	5,000	$1.003	$5,016.000

See all changes in directors' interest & trades for Clover Corporation Limited (CLV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CLV Management

Name	Position
Andrew Allibon	Chief Financial Officer,Company Secretary

CLV Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Clover Corporation Limited (CLV). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
0 (12.40%)	Perpetual Limited and its related bodies corporate
0 (10%)	Thai Union Group Public Company Limited
0 (6%)	Thorney Investment Group
0 (5.70%)	Anacacia Pty Limited
0 (5%)	Jeremy & Lynette King

CLV Calendar of Events

Date	Event
15 October 2027	Report (Annual)
22 September 2027	Report (Annual)
22 September 2027	Report (Prelim)
23 March 2027	Report (Interim)
19 November 2026	Div Pay Date
17 November 2026	AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us